Blueshift Asset Management LLC has recently made a notable entry into the shares of Teradyne, Inc. (NASDAQ:TER), marking a significant new stake in the company during the first quarter. This strategic acquisition involved 4,268 shares, valued at an approximate $353,000, underscoring a growing institutional interest in the Teradyne TER stock. This move highlights the dynamic landscape of stock market investment as major firms adjust their portfolios based on market performance and future outlook.
The acquisition by Blueshift Asset Management is not an isolated incident, as several other prominent institutional investors and hedge funds have also adjusted their positions in Teradyne. For instance, DAVENPORT & Co LLC significantly increased its stake by 29.8% in the first quarter, accumulating 5,094 shares valued at $421,000. Similarly, Park Avenue Securities LLC boosted its holdings by 56.0%, now owning 3,045 shares worth $252,000, reflecting widespread confidence in the company’s prospects.
Further demonstrating the broad appeal of NASDAQ trading in Teradyne, Crossmark Global Holdings Inc. expanded its position by 6.4%, bringing its total to 4,328 shares valued at $357,000. Asset Management One Co. Ltd. showed substantial growth, increasing its shares by 5.5% to a total of 68,612, worth $5,667,000. Perhaps the most dramatic increase came from Wealth Enhancement Advisory Services LLC, which dramatically increased its position by 306.9%, now holding 37,661 shares valued at $3,111,000. These movements collectively signify strong asset management confidence.
The cumulative effect of these institutional maneuvers is profound, with institutional investors now holding a commanding 99.77% of Teradyne’s stock, solidifying its status as a widely held company among major funds. Adding to the investment narrative, research analysts have offered varied perspectives on TER shares. While some prominent firms like The Goldman Sachs Group reissued a ‘sell’ rating with a target price of $85.00, others, such as Cowen, maintained a ‘buy’ rating. The consensus among analysts from MarketBeat data currently places Teradyne with an ‘Average Rating’ of ‘Hold’ and a consensus target price of $114.44.
From a financial performance standpoint, Teradyne’s stock opened at $104.16 on a recent Friday, showcasing its market activity. The company boasts a significant market capitalization of $16.71 billion, alongside a PE ratio of 36.04 and a P/E/G ratio of 2.18, indicating its valuation metrics. With a beta of 1.72, the stock demonstrates higher volatility compared to the overall market. Its 50-day moving average stands at $89.70, and its two-hundred day moving average is $92.80, with a twelve-month low of $65.77 and a high of $144.16, providing a comprehensive view of its trading range.
The company’s recent TER earnings report, released on Tuesday, July 29th, highlighted a positive beat, with reported earnings per share of $0.57, surpassing the consensus estimate of $0.54. Revenue for the quarter reached $651.80 million, also exceeding the $649.02 million consensus. Despite a 10.7% decrease in revenue compared to the same quarter last year, Teradyne maintained a net margin of 16.59% and an impressive return on equity of 18.16%, demonstrating robust profitability. Analysts project the company to post 3.88 EPS for the current fiscal year, indicating ongoing growth expectations.
In additional corporate news, Teradyne recently announced a quarterly dividend of $0.12 per share, paid on June 13th, representing an annualized dividend of $0.48 and a yield of 0.5%. The company’s payout ratio currently stands at 16.61%. Furthermore, the board approved a significant stock repurchase plan on April 28th, authorizing the buyback of up to $1.00 billion in outstanding shares, or approximately 8.1% of its stock. Such repurchase plans are often perceived as a strong signal from management that the company’s shares are undervalued, reinforcing confidence in the Teradyne investment. Insider activity also featured prominently, with the CEO selling 554 shares for $58,574.42, a transaction publicly disclosed, though corporate insiders collectively own a small fraction of the company’s stock.